Written question asked by Jim Shannon (Democratic Unionist Party) on Tuesday, 17 January 2023, in the House of Commons. It was due for an answer on Thursday, 19 January 2023. It was answered by Helen Whately (Conservative) on Monday, 23 January 2023 on behalf of the Department of Health and Social Care.
Breast Cancer: Drugs
- Question
-
To ask the Secretary of State for Health and Social Care, whether the breast cancer drug Abraxane will be made available on the NHS.
- Answer
-
Abraxane (nab-paclitaxel) is available to National Health Service patients for several indications including as a monotherapy or as part of combination chemotherapy for adjuvant, neoadjuvant and palliative indications in breast cancer in patients who are hypersensitive to paclitaxel or docetaxel or who are vulnerable to the side-effects of chemotherapy and require a reduction in the risks of treatment.
Secondary information
- Type
- Written question
- Reference
- 125358
- Session
- 2022-23
- Subjects
- Breast cancer Drugs
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-10-06 15:54:42 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/125358
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/125358
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/125358